ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1389

Clinical Characteristics and Treatment Outcome of a Cohort of Patients with Joint and Fascial Involvement in the Context of Chronic Graft versus Host Disease

Cristina Hidalgo Calleja1, Concepción Román Curto2, Luis Gómez-Lechón3, Maria Elisa Acosta2, Olga Compán4, Sonia Pastor2, Carlos Montilla Morales2, Lucía Pantoja Zarza5, María Dolores Sánchez González6 and Lucía López Corral2, 1Hospital Universitario Salamanca, Salamanca, Spain, 2Hospital Universitario de Salamanca, Salamanca, Spain, 3Hospital Francesc de Borga de Gandía, Valencia, Spain, 4Hospital Universitario de Salamanca, ´Salamanca, Spain, 5Complejo Asistencial Hospital General de Segovia, Segovia, Spain, 6Hospital Clínico Universitario de Valladolid, Valladolid, Spain

Meeting: ACR Convergence 2020

Keywords: Joint Structure, Scleroderma, Systemic

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Chronic graft-vs-host disease (cGVHD) is a major late complication of allogeneic hematopoietic stem cell transplantation (alloHSCT), typically occurring within three years post-transplant and affecting approximately 30%-50% of allogeneic transplant survivors. Although cGVHD can involve many organ systems, joint and fascial involvement is relatively common, little known   and can cause significant functional impairment.

Describe  the clinical/transplant related characteristics, the therapeutic management and the clinical outcome of a cohort of patients with joint and fascial involvement in the context of cGVHD.

Methods: Observational and retrospective study to describe the clinical characteristics of 28 patients affected by joint and fascial cGVHD. The usual demographic variables, the transplant reason disease, the type of transplant,laboratory parameters, rescue therapies and their response were collected.  The statistical analysis was done with Microsoft Excel 2007.

Results: Seventeen (60.7%) patients were male and 11 (39.35%) were women with a mean age of 48.75 years (range from 10 to 74). Acute myeloid leukemia was the most frequent cause of the transplant in 11 patients (39.3%)
Transplant related characteristics are reflected in Table 1 and the clinical manifestations, therapies received and their response in Table 2..  Eighteen (64,3%) presented irreversible contracture due to sclerosis that negatively impacts their quality of life and physical function (11/39%).
Four (14.2%) patients died during their follow-up, being the cause of death in 2 cases due to sepsis, in 1 case due to  leukemia relapse and in 1 case attributable to cGVHD. 

Conclusion: Nonspecific joint symptoms such as stiffness, edema or arthromyalgia may be factors that predict the development of joint/fascial involvement in cGVHD.
They should be closely monitored in order to be able to perform early stage diagnoses and implementation of proper treatment, including rehabilitation, in order to restore function and improve the quality of life of these patients.


Disclosure: C. Hidalgo Calleja, None; C. Román Curto, None; L. Gómez-Lechón, None; M. Acosta, None; O. Compán, None; S. Pastor, None; C. Montilla Morales, None; L. Pantoja Zarza, None; M. Sánchez González, None; L. López Corral, None.

To cite this abstract in AMA style:

Hidalgo Calleja C, Román Curto C, Gómez-Lechón L, Acosta M, Compán O, Pastor S, Montilla Morales C, Pantoja Zarza L, Sánchez González M, López Corral L. Clinical Characteristics and Treatment Outcome of a Cohort of Patients with Joint and Fascial Involvement in the Context of Chronic Graft versus Host Disease [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/clinical-characteristics-and-treatment-outcome-of-a-cohort-of-patients-with-joint-and-fascial-involvement-in-the-context-of-chronic-graft-versus-host-disease/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/clinical-characteristics-and-treatment-outcome-of-a-cohort-of-patients-with-joint-and-fascial-involvement-in-the-context-of-chronic-graft-versus-host-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology